About 6% of the plan participants were using the weight-loss drugs. Covering GLP-1s, for an enrollee who took the drug, cost the plans surveyed an average of $7,400 per year.

GLP-1 cost pressure is now a talent retention issue. A new study found that 29% of employees would switch jobs for coverage, but these drugs aren't cheap for employers.

Households that earn the median annual income would need to spend an average of 7.3% of their earnings to pay for 2 mg of Ozempic.

The survey also noted that 34% of firms require lifestyle or clinical support programs in order for employees to receive GLP-1 agonists for weight loss.